ENERGI‑F701
Metabolic Disorders (exploratory)
PreclinicalActive
Key Facts
Indication
Metabolic Disorders (exploratory)
Phase
Preclinical
Status
Active
Company
About Energenesis Biomedical
Taiwanese biotech advancing small‑molecule topical therapies for diabetic wound healing.
View full company profile